# A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome

> **NCT04141969** · PHASE2,PHASE3 · COMPLETED · sponsor: **Optimal Health Research** · enrollment: 100 (actual)

## Conditions studied

- Post-Lyme Disease Syndrome (PLDS)

## Interventions

- **DIETARY_SUPPLEMENT:** RLP
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04141969
- **Lead sponsor:** Optimal Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-29
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-03-28
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2021-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04141969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04141969, "A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04141969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*